Pharmaceutical

Global Ophthalmic drugs Market Revenue Projected Around USD 37,700 Million By 2026

Facts and Factors has authored “Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, and Others), By Disease Indication (Inflammation/ Infection, Retinal Disorders, Dry Eye, Glaucoma, Allergies, and Others), By Distribution Channel (Online Sales, Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026”. Based on our analysis, the global ophthalmic drugs market in 2019 is over USD 27,000 million and is expected to reach around USD 37,700 million by 2026. The anticipated CAGR for the global ophthalmic drugs market is around 4.6% from 2020 to 2026.

Ophthalmic drugs, also referred to as eye medications, are solid, liquid, or semi-solid formulations that are intended to apply on the eyelids and conjunctiva. The drugs are certain emulsions, ointments, and/or active pharmaceutical ingredient(s).

High prevalence of ocular disease cases likely to bolster the ophthalmic drug market

The visual impairment incidences have been surging considerably worldwide irrespective of the age group. This challenging situation has urged drug manufacturers and pharmaceutical companies to design and supply effective medications against this rapidly spreading disorder. Hence, the introduction of novel effective ophthalmic drugs bolsters the global ophthalmic drug market. Exposure to air and water pollution poses a greater risk to the eyes. Thus, surging the demand for the drugs and propelling the global ophthalmic drug market.

Request Free Sample Copy of Research Report @ https://www.fnfresearch.com/sample/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by/news

 

Ophthalmic drugs-associated side effects expected to hamper the ophthalmic market

Eye treatment involves a risky operation and has various side effects. In some cases, ophthalmic drugs fail to maintain the intraocular pressure of the eye while treatment. In most of the cases, the medicine may cause internal burning in the eye and/or temporary blurred vision. Owing to these attributes, the ophthalmic drugs market enters the declining phase.

Anti-infective drug class leads the global ophthalmic drug market

The anti-infective drug category, from the past few years, has been holding the dominating position in the global ophthalmic market. In 2019, the category accounts for more than one-third of the market share in terms of revenue. However, the anti-glaucoma drugs are projected to augment at a relatively faster CAGR throughout the forecast period.

Over-the-counter drug type accounts for higher sales and revenue share

Based on the type segment, ophthalmic drugs are categorized into prescription drugs and over-the-counter drugs. Among both, over-the-counter drug type holds around two-third share in the overall sales and revenue. However, the prescription drug category is anticipated to grow at higher CAGR between 2020 and 2026.

Inquire more about this report before purchase @ https://www.fnfresearch.com/buynow/su/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by/news

Retail pharmacies expect better sales and revenue share during the forecast period

Despite the consecutive decline in the volume sales, the revenue generated by retail pharmacies is thrusting at a considerable rate. Based on the forecast, the drug category is likely to follow the same revenue growth trend. However, the hospital pharmacies category holds the leading position in the global market revenue generation.

Key market players

Some of the key players driving the global ophthalmic drugs market are Santen Pharmaceutical Co. Ltd., Bayer AG, ALLERGAN, Novartis AG, Pfizer Inc., Genentech Inc., Oxurion NV, Bausch Health Companies Inc., and Regeneron Pharmaceuticals Inc., among others.

In February 2019, Bausch Health Companies Inc.procures the patent medicine EM-100 investigational eye drop designed by Eton Pharmaceuticals EM-100 for the treatment of itching associated with the allergies in eyes.

Browse the full “Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, and Others), By Disease Indication (Inflammation/ Infection, Retinal Disorders, Dry Eye, Glaucoma, Allergies, and Others), By Distribution Channel (Online Sales, Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026″ report at https://www.fnfresearch.com/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by

The global ophthalmic drugs market is segmented as:

Global Ophthalmic Drugs Market: Type Segmentation Analysis

  • Over-the-Counter Drugs
  • Prescription Drugs

Global Ophthalmic Drugs Market: Drug Class Segmentation Analysis

  • Anti-Infective Drugs
    • Anti-Bacterial Drugs
    • Anti-Fungal Drugs
    • Anti-Viral Drugs
    • Others
  • Anti-Glaucoma Drugs
    • Prostaglandin Analogs
    • Alpha Agonist
    • BetaBlockers
    • Combined Medication
    • Others
  • Anti-inflammatory Drugs
    • Steroids
    • Non-Steroidal Anti-Inflammatory Drugs
  • Anti-Allergic Drugs
  • Others

Global Ophthalmic Drugs Market: Disease Indication Segmentation Analysis

  • Inflammation/ Infection
  • Retinal Disorders
  • Dry Eye
  • Glaucoma
  • Allergies
  • Others

Global Ophthalmic Drugs Market: Distribution Channel Segmentation Analysis

  • Online Sales
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Global Ophthalmic DrugsMarket: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle-East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle-East Africa  

Request customized copy of report @ https://www.fnfresearch.com/custom/448/news

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

Global Headquarters

Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal – 200120, China
Tel: +86 21 80360450

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Tags

Related Articles

Back to top button
Close